|
|
News Breaks | | | | September 4, 2012 | | 06:38 EDT |  | HUM | Humana upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Humana citing valuation and its belief that margin pressure from higher utilization is fixable. The firm also believes a Republican win in November could accelerate Humana's Medicare Advantage growth opportunity. Leeerink raised its price target range for shares to $84-$92 from $66-$74. | |
|
News For HUM From The Last 14 Days Check below for free stories on HUM the last two weeks. |
|
|
| May 20, 2013 | | 09:47 EDT |  | HUM | Humana management to meet with JPMorgan
 Subscribe for More Information | | | May 16, 2013 | | 10:10 EDT |  | HUM | Quest Diagnostics Humana acquires Concentra's laboratory business
Subscribe for More Information | | | May 9, 2013 | | 08:51 EDT | | HUM | Humana appoints Roy A. Beveridge, M.D., as Chief Medical Officer
Humana (HUM) has appointed Roy A. Beveridge, M.D. as Senior VP and Chief Medical Officer, effective June 17. Dr. Beveridge is currently Chief Medical Officer for McKesson Specialty Health, a subsidiary of McKesson (MCK). | | | May 8, 2013 | | 10:10 EDT | | HUM | Humana announces plans to add 500 telesales positions
Subscribe for More Information | |
|
|
|
|
|
|
